|
"huang w t"的相關文件
顯示項目 26-35 / 209 (共21頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 國立成功大學 |
2022 |
Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non–Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
|
Wang, M.;Yang, J.C.-H.;Mitchell, P.L.;Fang, J.;Camidge, D.R.;Nian, W.;Chiu, Chiu C.-H.;Zhou, J.;Zhao, Y.;Su, W.-C.;Yang, T.-Y.;Zhu, V.W.;Millward, Millward M.;Fan, Y.;Huang, W.-T.;Cheng, Y.;Jiang, L.;Brungs, D.;Bazhenova, L.;Lee, C.K.;Gao, B.;Xu, Y.;Hsu, W.-H.;Zheng, L.;J�nne, P.A. |
| 國立成功大學 |
2022 |
Association between sarcopenia and survival in patients with gynecologic cancer: A systematic review and meta-analysis
|
Lin, W.-L.;Nguyen, T.-H.-Y.;Lin, C.-Y.;Wu, L.-M.;Huang, W.-T.;Guo, H.-R. |
| 國立成功大學 |
2022 |
Role of high ubiquitin‑conjugating enzyme E2 expression as a prognostic factor in nasopharyngeal carcinoma
|
Kao, W.-C.;Hsu, S.-H.;Lin, C.-L.;Lin, C.-Y.;Chen, S.-W.;Chen, Y.-X.;Chen, Chen C.-H.;Lee, S.-W.;Tsao, C.-J.;Huang, W.-T.;Chen, S.-H.;Hsiao, S.-Y. |
| 國立成功大學 |
2022 |
Investigation of the incidence trend of follicular lymphoma from 2008 to 2017 in Taiwan and the United States using population-based data
|
Su, Y.-C.;Chiu, B.H.-C.;Li, H.-J.;Yang, W.-C.;Chen, T.-Y.;Yeh, S.-P.;Wang, M.-C.;Huang, W.-T.;Lee, M.-Y.;Lin, S.-F. |
| 國立成功大學 |
2022 |
Targeted Next-generation Sequencing Reveals a Wide Morphologic and Immunophenotypic Spectrum of Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma
|
Hang, J.-F.;Yuan, C.-T.;Chang, K.-C.;Wang, R.-C.;Chen, B.-J.;Hsieh, P.-P.;Huang, W.-T.;Chuang, W.-Y.;Chen, T.-W.;Yeh, Yeh Y.-C.;Lin, S.-Y.;Hsiao, C.-H.;Chou, S.-C.;Tseng, C.-E.;Pan, S.-T.;Chang, S.-L.;Chuang, S.-S. |
| 臺大學術典藏 |
2021-10-27T03:22:22Z |
Primary effusion lymphoma in Taiwan shows two distinctive clinicopathological subtypes with rare human immunodeficiency virus association
|
Chen B.-J.; Wang R.-C.; Ho C.-H.; CHANG-TSU YUAN; Huang W.-T.; Yang S.-F.; Hsieh P.-P.; Yung Y.-C.; Lin S.-Y.; Hsu C.-F.; Su Y.-Z.; Kuo C.-C.; Chuang S.-S. |
| 臺大學術典藏 |
2021-10-14T02:46:06Z |
Prediction of outcome of patients with metastatic breast cancer: Evaluation with prognostic factors and Nottingham prognostic index
|
Liu M.-T.; Huang W.-T.; Wang A.-Y.; Huang C.-C.; CHAO-YUAN HUANG; Chang T.-H.; Pi C.-P.; Yang H.-H. |
| 臺大學術典藏 |
2021-10-04T07:15:40Z |
Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study
|
Wei Y.-F.; Huang W.-T.; Liu T.-C.; Shieh J.-M.; Chian C.-F.; Wu M.-F.; Chang C.-C.; Lin C.-H.; JEN-CHANG KO; Lin C.-M.; Hsia T.-C. |
| 臺大學術典藏 |
2021-09-23T07:28:12Z |
Dual-emission Eu-doped Ca2−xSrxPN3 nitridophosphate phosphors prepared by hot isostatic press
|
Fang, M.-H.; Hsueh, H.-P.; Vasudevan, T.; Huang, W.-T.; Bao, Z.; Majewska, N.; Mahlik, S.; Sheu, H.-S.; Liu, R.-S.; RU-SHI LIU |
| 臺大學術典藏 |
2021-09-01T01:54:01Z |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
Hsu C.; Yang T.-S.; Huo T.-I.; Hsieh R.-K.; Yu C.-W.; Hwang W.-S.; Hsieh T.-Y.; Huang W.-T.; Chao Y.; Meng R.; ANN-LII CHENG |
顯示項目 26-35 / 209 (共21頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
